Surgery and Surgical Robotics
IRRAS’s Intracranial Bleeding Management Device Used on First U.S. Patient
IRRAS AB, a commercial-stage medical-technology company, today announced that the first patient in the United States was successfully treated with IRRAflow, the company’s initial product that offers an innovative, therapeutic approach to the fluid management of patients with intracranial bleeding. “The US is the largest market for intracranial procedures, and we are making significant progress engaging neurocritical care centers and specialty hospitals across the country,” said Kleanthis G. Xanthopoulos, Ph.D.,…
Read MoreTitan Medical’s Sport Robotic System Nearing Commercialization
Titan Medical Inc., a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery, announces that it has completed the system engineering confidence build for all components of its single-port robotic surgery system. This accomplishment highlights the completion of a new camera system along with the…
Read MoreBrainScope Receives FDA Clearance for Multi-Parameter Concussion Assessment
BrainScope, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has received FDA clearance to include additional language in its product’s Indications for Use (IFU), adding key terminology related to “multi-modal, multi-parameter assessment” of “concussion” and “mild Traumatic Brain Injury”, as well as an expanded and…
Read MoreTransEnterix Prepping for a $75M Offering
TransEnterix is planning for an upcoming $75 million offering, according to a recently posted SEC filing. The Research Triangle Park, N.C.-based company said that Stifel, Nicolaus & Company will serve as its sale agent in the offering, but the company has not yet announced how many shares it plans to float in the sale. The round…
Read MoreConMed Spending $365M on Buffalo Filter’s Surgical Technology
CONMED Corporation today announced a definitive agreement to acquire privately-held Buffalo Filter LLC (Buffalo Filter) for $365 million on a cash-free, debt-free basis. The transaction is expected to be financed through a combination of new convertible notes and an expanded and amended credit facility. The transaction is subject to customary closing conditions, including receipt of U.S.…
Read MoreIs the Appendix the Key to Parkinson’s Disease?
Parkinson’s disease, a degenerative neurological disorder that impairs brain cells and causes movement problems, could have its origins in the appendix, a new study suggests. The vestigial organ, the researchers say, could be the source of proteins that can find their way to the brain and once there, extend a deadly grip on nerve cells.…
Read MoreUK’s First Fetal Surgeries for Spina Bifida Successful
In a UK first, a team from University College London Hospitals (UCLH), University College London (UCL) and Great Ormond Street Hospital (GOSH) has successfully operated on the spinal cords of two babies with spina bifida still developing in the womb. The fetoscopic surgery was a success, with surgeons able to repair the defect in the spine…
Read MoreMedtronic to buy Mazor Robotics for $1.64 Billion
Mazor Robotics Ltd., an Israeli biotech firm that develops robotic surgical systems, announced Friday it was being acquired by Irish-American medical device company Medtronic for a sum of $1.64 billion, the biggest-ever “exit” for an Israeli biotech company. Medtronic previously owned an 11 percent stake in Mazor, which provides among its products a suite of…
Read MoreXACT Robotics Receives CE Mark for Robotic Navigation and Steering System
XACT Robotics, a pioneer in robotic navigation and steering solutions for percutaneous image-guided procedures, announced today that it has received CE Mark approval for its robotics navigation and steering system for image-guided percutaneous procedures, such as ablations and biopsies. The Company also announced that it has raised $5 million in round C investment. The funds will mainly…
Read MoreNew Biomedical Review Finds Failure Rate in Some Surgical Mesh Treatments Unacceptably High
Failure rates in some treatments using surgical mesh are unacceptably high according to a newly published comprehensive biomedical review that considers the findings from peer-reviewed scientific articles assessing its use. In addition, the review concludes that more experiments should have been conducted to properly assess how surgical mesh would behave in some of the bodily…
Read More